NOVEL ANTIANDROGEN ARN-509 IN HIGH-RISK NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Shore, Neal D.
Antonarakis, Emmanuel S.
Ryan, Charles J.
Berry, William R.
Liu, Glenn
Higano, Celestia
Maneval, Edna Chow
Bandekar, Rajesh
de Boer, Carla J.
Todd, Mary B.
Yu, Margaret K.
Rathkopf, Dana E.
Smith, Matthew R.
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.1961
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP87-16
引用
收藏
页码：E1090 / E1090
页数：1
相关论文
共 50 条
  • [21] Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
    Boudadi, Karim
    Antonarakis, Emmanuel S.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 1 - 9
  • [22] Pharmacokinetics (PK) and safety of ARN-509 with abiraterone acetate (AA) and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Posadas, Edwin M.
    Chit, Kim N.
    de Wit, Ronald
    de Jonge, Maja J. A.
    Attard, Gerhardt
    Friedlander, Terence
    Yu, Margaret
    Hellemans, Peter
    Chien, Caly
    Abrams, Charlene
    Gonzalez, Martha
    Trudel, Geralyn C.
    Chauhan, Vijay
    Saad, Fred
    CANCER RESEARCH, 2015, 75
  • [23] Treatment Approaches for Nonmetastatic Castration-Resistant Prostate Cancer
    Yildizhan, Mehmet
    Gemalmaz, Hakan
    Ertek, Mehmet Sirin
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2015, 14 (02): : 120 - 127
  • [24] Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
    Altavilla, Amelia
    Casadei, Chiara
    Lolli, Cristian
    Menna, Cecilia
    Ravaglia, Giorgia
    Gurioli, Giorgia
    Farolfi, Alberto
    Brighi, Nicole
    Conteduca, Vincenza
    Burgio, Salvatore Luca
    Schepisi, Giuseppe
    Rossi, Lorena
    Gargiulo, Stefania
    Lisotti, Ivana
    De Giorgi, Ugo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2091 - 2099
  • [25] Re: Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 202 (04): : 660 - 661
  • [26] Nonmetastatic Castration-resistant Prostate Cancer: A Modern Perspective
    Cancian, Madeline
    Renzulli, Joseph F., II
    UROLOGY, 2018, 116 : 13 - 16
  • [27] Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
    Hussain, Maha
    Fizazi, Karim
    Saad, Fred
    Rathenborg, Per
    Shore, Neal
    Ferreira, Ubirajara
    Ivashchenko, Petro
    Demirhan, Eren
    Modelska, Katharina
    Phung, De
    Krivoshik, Andrew
    Sternberg, Cora N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2465 - 2474
  • [28] Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
    Fizazi, Karim
    Shore, Neal
    Tammela, Teuvo L.
    Ulys, Albertas
    Vjaters, Egils
    Polyakov, Sergey
    Jievaltas, Mindaugas
    Luz, Murilo
    Alekseev, Boris
    Kuss, Iris
    Le Berre, Marie-Aude
    Petrenciuc, Oana
    Snapir, Amir
    Sarapohja, Toni
    Smith, Matthew R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (11): : 1040 - 1049
  • [29] Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
    Sternberg, Cora N.
    Fizazi, Karim
    Saad, Fred
    Shore, Neal D.
    De Giorgi, Ugo
    Penson, David F.
    Ferreira, Ubirajara
    Efstathiou, Eleni
    Madziarska, Katarzyna
    Kolinsky, Michael P.
    Cubero, Daniel I. G.
    Noerby, Bettina
    Zohren, Fabian
    Lin, Xun
    Modelska, Katharina
    Sugg, Jennifer
    Steinberg, Joyce
    Hussain, Maha
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23): : 2197 - 2206
  • [30] Denosumab in men with nonmetastatic castration-resistant prostate cancer (CRPC) at high risk for bone metastases
    Smith, M. R.
    Fizazi, K.
    Miller, K.
    Egerdie, B.
    Morote, J.
    Tammela, T. L.
    Wong, S.
    Ye, Z.
    Braun, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S682 - S682
12345